What’s the Problem?
This recall affects all lots of Amneal Metformin Hydrochloride Extended Release Tablets, USP, 500 mg and 750 mg.
Although tests identified the presence of above acceptable limits for N-Nitrosodimethylamine (NDMA) in only 7 lots of Amneal Metformin, the firm decided to recall all lots of the drug “out of an abundance of caution,” FDA said.
The recalled metformin was distributed nationwide to Wholesalers, Distributors, Retailers and Repackagers. Affected lot numbers can be found on the FDA recall page.
If you were prescribed any Amneal Metformin that is affected by this recall, you should not stop taking it without talking to your doctor first, as doing so could have adverse health consequences. Anyone concerned about a potential reaction to NDMA in metformin should go to a hospital emergency room immediately.
This recall began on May 29, 2020.
Do I Have an Amneal Metformin Recall Class Action Lawsuit?
The Pharmaceutical Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Amneal Metformin Recall Class Action Lawsuits. We are handling individual litigation nationwide and currently accepting new injury and death cases in all 50 states.
If you or a loved one has been injured by metformin, you should contact our law firm immediately. You may be entitled to a settlement by filing a suit and we can help.